NPPB and hydrops fetalis: The primary endpoint was a composite of time to death, urgent heart transplantation or VAD implantation; time to a non-fatal HF event requiring intravenous vasoactive therapy; and time-averaged change in NT-proBNP from baseline to 14 weeks.